SurModics
SRDX
#6822
Rank
โ‚ฌ0.52 B
Marketcap
36,88ย โ‚ฌ
Share price
0.00%
Change (1 day)
-2.85%
Change (1 year)
Categories

SurModics (SRDX) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ50.2 Million

According to SurModics's latest financial reports the company's total liabilities are โ‚ฌ50.2 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SurModics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30โ‚ฌ53.57 M-13.83%
2023-09-30โ‚ฌ62.17 M21.75%
2022-09-30โ‚ฌ51.06 M8.44%
2021-09-30โ‚ฌ47.09 M46.44%
2020-09-30โ‚ฌ32.15 M-6.15%
2019-09-30โ‚ฌ34.26 M-28.38%
2018-09-30โ‚ฌ47.84 M124.38%
2017-09-30โ‚ฌ21.32 M-8.3%
2016-09-30โ‚ฌ23.25 M279.95%
2015-09-30โ‚ฌ6.11 M25.91%
2014-09-30โ‚ฌ4.86 M-18.9%
2013-09-30โ‚ฌ5.99 M-17.73%
2012-09-30โ‚ฌ7.28 M-42.43%
2011-09-30โ‚ฌ12.65 M8.28%
2010-09-30โ‚ฌ11.68 M28.62%
2009-09-30โ‚ฌ9.08 M-74.13%
2008-09-30โ‚ฌ35.11 M23.72%
2007-09-30โ‚ฌ28.38 M194.59%
2006-09-30โ‚ฌ9.63 M33.96%
2005-09-30โ‚ฌ7.19 M-41.55%
2004-09-30โ‚ฌ12.3 M22.35%
2003-09-30โ‚ฌ10.05 M36.08%
2002-09-30โ‚ฌ7.39 M37.74%
2001-09-30โ‚ฌ5.36 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Nektar Therapeutics
NKTR
โ‚ฌ0.18 B 269.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ44.50 B 88,540.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ17.26 M-65.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.51 B 918.71%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚ฌ97.41 B 193,940.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ28.24 B 56,155.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
โ‚ฌ5.02 B 9,908.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚ฌ0.20 B 300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ5.66 B 11,186.96%๐Ÿ‡บ๐Ÿ‡ธ USA